Analysts at Evercore ISI have downgraded Cardinal Health Inc. CAH, -0.72% to a in-line rating from an outperform rating. Analysts wrote Monday that the healthcare services company’s stock valuation now fully reflects both its improving fundamentals as well as potential upside. Analysts wrote that “improvement in Cardinal’s medical supplies and products segment has been slower than anticipated.” Analysts wrote that the company’s pharmaceuticals business is benefiting both from higher prescription usage and favorable drug pricing trends.